Norflex

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

Orphenadrine citrate

Inapatikana kutoka:

iNova Pharmaceuticals Australia Pty Ltd

Darasa:

Medicine Registered

Taarifa za kipeperushi

NORFLEX™

_Orphenadrine citrate 100mg tablets_
CONSUMER MEDICINE INFORMATION

WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about NORFLEX tablets.
However it does not contain all the
available information. Your doctor
and pharmacist have more
information about this medicine.
IF YOU HAVE ANY QUESTIONS ABOUT
NORFLEX THAT ARE NOT ANSWERED
BY THIS LEAFLET, PLEASE ASK YOUR
DOCTOR OR PHARMACIST.
All medicines have risks and
benefits. Your doctor has weighed
the risks of your taking NORFLEX
against the benefits before
prescribing it for you.
IF YOU ARE WORRIED ABOUT TAKING
THIS MEDICINE PLEASE TALK TO YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH YOUR
MEDICINE AS YOU MAY WANT TO READ
IT AGAIN.
WHAT NORFLEX IS
USED FOR
The name of your medicine is
NORFLEX. It contains orphenadrine
citrate. Orphenadrine citrate is a
skeletal muscle relaxant. It acts in the
central nervous system to produce its
muscle relaxant effects.
NORFLEX is used to help relax
certain muscles in your body and to
relieve the pain and discomfort
caused by sprains, strains or other
injury to your muscles.
Your doctor may have prescribed
NORFLEX for another purpose.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY THIS MEDICINE
HAS BEEN PRESCRIBED FOR YOU.
BEFORE YOU TAKE
NORFLEX
_WHEN YOU MUST NOT TAKE IT_
DO NOT TAKE NORFLEX IF:
•
YOU HAVE HAD AN ALLERGIC
REACTION TO ORPHENADRINE CITRATE
OR OTHER SIMILAR MEDICINES, OR
TO ANY OF THE INGREDIENTS LISTED
AT THE END OF THIS LEAFLET.
•
YOU HAVE ANY OF THE FOLLOWING:
-
GLAUCOMA
 (high pressure in the eye);
-
INTESTINAL BLOCKAGE, STOMACH
ULCER OR OESOPHAGEAL DISEASE;
-
ENLARGED PROSTATE OR BLADDER
OBSTRUCTION;
-
MYASTHENIA GRAVIS
 (a disease of the muscles causing
drooping eyelids, double vision,
difficulty in speaking and
swallowing, and sometimes
muscle weakness in the arms or
legs).
•
AFTER THE EXPIRY DATE ON THE
BOTTLE
•
IF THE PACKAGING SHOWS SIGNS OF
TAMPERING
DO NOT GIVE THIS MEDICINE TO A CHILD
UNDER THE AGE OF 12 YEARS.
Safety and effectiveness in c

Tabia za bidhaa

iapnorfx11108.doc 
PRODUCT INFORMATION 
NORFLEX 

COMPOSITION 
Each tablet contains orphenadrine citrate 100 mg. 

ACTIONS 
Skeletal muscle relaxant. 

INDICATIONS 
Relief of painful muscle spasm
associated with fibrositis, whiplash injuries, torticollis, 
prolapsed intervertebral disc, strains, sprains and
similar conditions.  Has also been shown to 
be of value in tension headache and persistent hiccup. 

CONTRAINDICATIONS 
Orphenadrine shows some anticholinergic activity and should
not be used in patients with 
glaucoma, prostatic hypertrophy or obstruction
at the bladder neck, or myasthenia gravis. 

PRECAUTIONS 
Orphenadrine may impair the ability of the patient to
engage in potentially hazardous 
activities such
as operating machinery or driving a motor vehicle; ambulatory patients should 
therefore be cautioned accordingly. Orphenadrine citrate should
be used with caution in 
patients with tachycardia, cardiac
decompensation, coronary insufficiency, cardiac 
arrhythmias. Safety of continuous long-term therapy with
orphenadrine has not been 
established.  Therefore if orphenadrine is prescribed
for prolonged use, periodic monitoring of 
blood, urine and liver function is recommended. 

Use in Pregnancy: Category B2 

ADVERSE REACTIONS 
Side effects rarely occur at the recommended dosage. 
Those encountered are associated with 
anticholinergic activity and may include nausea, dry mouth,
blurring of vision.  Rarely, rash or 
drowsiness may occur.  These symptoms disappear rapidly with
a reduction in dosage or 
cessation of medication.  No toxic effects have been observed. 
iapnorfx11108.doc 
OVERDOSAGE 

Symptoms:  Symptoms of orphenadrine overdosage are excitement,
confusion, delirium 
leading to coma.  Convulsions and tachycardia with dilated
pupils and urinary retention may 
occur. 

Treatment:  Gastric lavage should